| PRE-MEETING SYMPOSIA | ||
| SYMPOSIUM ON MALIGNANT SKIN INFLAMMATION | ||
| 8.00AM-8.10AM | Welcome address organizing committee | |
| MALIGNANT INFLAMMATION – ROLE OF INFECTIONS AND ENVIRONMENTAL DRIVERS | ||
| 8.10AM-8.30AM | Keynote lecture: Bacteria fuel malignant inflammation and disease activity in CTCL | Niels Ødum, Copenhagen, Denmark |
| 8.30AM-8.50AM | Microbial triggers and clonal evolution in CTCL pathogenesis | Sergei Koralov, New York, NY, USA |
| 8.50AM-9.10AM | Chronic T cell activation by CD1a and Staphylococcal lipids | Annemieke de Jong, New York, NY, USA |
| 9.10AM-9.30AM | AhR signaling drives defective type I IFN signaling in mycosis fungoides | Rachael Clark, Boston, MA, USA |
| 9.30AM-9.50AM | Infectious and environmental drivers of CTCL | Larisa Geskin, New York, NY, USA |
| 10.00AM-10.30AM | COFFEE BREAK | |
| ROLE OF THE MICROENVIRONMENT | ||
| 10.30AM-10.50AM | The micromilieu in CTCL: From inflammation over tumor progress to antitumoral response | Gabor Dobos, Berlin, Germany |
| 10.50AM-11.10AM | Targeting immunosuppressive macrophages in the tumor microenvironment of CTCL | Christiane Querfeld, Duarte, CA, USA |
| 11.10AM-11.30AM | The role of cancer-associated fibroblasts in MF | Emmilia Hodak, Tel Aviv, Israel |
| 11.30AM-11.50PM | ADCC in lymphoma treatment – A spotlight on NK cells? | Emmanuella Guenova, Lausanne, Switzerland |
| 12.00PM-1.00PM | SPONSORED LUNCH SYMPOSIUM | |
| PATHOGENESIS AND ITS TRANSLATION | ||
| 1.00PM-1.20PM | Towards a better understanding of the CTCL cellular and molecular landscape | Muzlifah Haniffa, Newcastle, UK |
| 1.20PM-1.40PM | Insights into pathogenesis and translational strategies for CTCL | Michael Girardi, New Haven, CT, USA |
| 1.40PM-2.00PM | An individualized approach to therapy of advanced MF in the era of personalized medicine | Oleg Akilov, Pittsburgh, PA, USA |
| 2.00AM-2.20AM | Indolent vs. aggressive disease | Patrick M. Brunner, New York, NY, USA |
| 2.20AM-2.40AM | COFFEE BREAK | |
| PATHOGENESIS BASED TREATMENT STRATEGIES | ||
| 2.40PM-3.00PM | CTCL: unraveling the mechanisms of long-term disease control | Adèle de Masson, Paris, France |
| 3.00PM-3.20PM | New treatment targets | Martine Bagot, Paris, France |
| 3.20PM-3.40PM | Therapeutic mechanisms in CTCL: Lessons learnt from photo(chemo)therapy | Peter Wolf, Graz, Austria |
| 3.40PM-4.00PM | The association of CTCL with inflammatory skin disorders and its treatments - True causality or misdiagnosis? | Shamir Geller, New York, NY, USA |
| 4.00PM-4.15PM | Concluding remarks and awards | |
| 01.00PM - 04.00PM | Pre-Meeting Symposium: Research Techniques in Atopic Dermatitis (Registration via IEC website required) | International Eczema Council |
| ISDS 2023 CONFERENCE OPENING | ||
| 04.30PM - 04.40PM | Welcome Address | Organizing Committee |
| 04.40PM -05.00PM | Setting the Stage | Georg Stingl, Vienna, Austria |
| 05.00PM - 05.30PM | Keynote lecture “Immune system-driven skin fibrosis” | Richard Flavell, New Haven, CT, USA |
| 05.30PM - 06.00PM | Type 2 immunity across diseases | Bart Lambrecht, Ghent, Belgium |
| 06.00PM - 07.00PM | Oral presentations from selected abstracts | More information |
| 07.00PM - 10.00PM | Reception and poster viewing | More information |
| 08.00 AM – 09.30 AM | Sponsored Breakfast Symposium | |
| 09.30 AM – 09.45 AM | BREAK | |
| 09.45 AM – 10.15 AM | Innate immunity in the skin | Michel Gilliet, Lausanne, Switzerland |
| 10.15 AM – 10.45 AM | The microbiome in inflammatory skin diseases | Heidi Kong, Bethesda, MD, USA |
| 10.45 AM – 11.15 AM | Developing a human skin cell atlas | Muzlifah Haniffa, Newcastle, United Kingdom |
| 11.15 AM – 11.45 AM | Oral presentations from selected abstracts | |
| 11.45 AM – 12.00 PM | BREAK | |
| 12.00 PM – 01.30 PM | Sponsored Lunch Symposium | |
| 01.30 PM – 01.45 PM | BREAK | |
| 01.45 PM – 02.15 PM | Mitochondrial ROS and cytoplasmic nucleic acid sensing set the inflammatory tone in human skin | Rachael Clark, Boston, MA, USA |
| 02.15 PM – 02.45 PM | Cutaneous T cell compartments in health and immunodeficiency | Georg Stary, Vienna, Austria |
| 02.45 PM – 03.15 PM | Chronic inflammation – what we learn from cutaneous lymphomas | Patrick M. Brunner, New York, NY, USA |
| 03.15 PM – 03.45 PM | Oral presentations from selected abstracts | |
| 03.45 PM – 04.15 PM | COFFEE BREAK | |
| 04.15 PM – 04.45 PM | Dissecting the role of IL-13 in health and disease | Johannes U. Mayer, Marburg, Germany |
| 04.45 PM – 05.15 PM | Janus kinases in inflammation | Massimo Gadina, Bethedsa, MD, USA |
| 05.15 PM – 05.45 PM | Psoriasis | Johann Gudjonsson, Ann Arbor, MI, USA |
| 05.45 PM – 06.15 PM | Newly identification of a CXCR6+ pathogenic skin-resident CD4+ T cell subset in a mouse model of allergic dermatitis that requires CXCL16 for its maintenance | Kenji Kabashima, Kyoto, Japan |
| Conference Networking Event (bus transfer) |
| 08.00 AM – 09.30 AM | Oral presentations from selected abstracts | |
| 09.30 AM – 09.45 AM | BREAK | |
| 09.45 AM – 10.15 AM | Neuronal immunology interactions | Dan Kaplan, Pittsburgh, PA, USA |
| 10.15 AM – 10.45 AM | Itch and neuroinflammation | Brian Kim, New York, NY, USA |
| 10:45 PM– 11:15 AM | "Of mice and men” - A Tale of Inflammatory Skin Diseases | Nicole Ward, Nashville, TN, USA |
| 11:15 AM – 11.45 AM | Oral presentations from selected abstracts | |
| 11.45 PM – 12.00 PM | BREAK | |
| 12.00 PM – 01.30 PM | Sponsored Lunch Symposium | |
| 01.30 PM – 01.45 PM | BREAK | |
| 01.45 PM – 02.15 PM | Advances in atopic dermatitis | Alan Irvine, Dublin, Ireland |
| 02.15 PM – 02.45 PM | Alopecia areata | Ralf Paus, Miami, FL, USA |
| 02.45 PM – 03.15 PM | Atopic dermatitis & alopecia areata: Common mechanisms and targets | Emma Guttman, New York, NY, USA |
| 03.15 PM – 03.45 PM | Oral presentations from selected abstracts | |
| 03.45 PM – 04.15 PM | COFFEE BREAK | |
| 04.15 PM – 04.45 PM | Oral presentations from selected abstracts | |
| 04.45 PM – 05.15 PM | Hidradenitis suppurativa | James G. Krueger, New York, NY, USA |
| 05.15 PM – 05.45 PM | Emerging opportunities in vitiligo | John Harris, Worcester, MA, USA |
| 05.45 PM – 06.45 PM | Oral presentations from selected abstracts | |
| 06.45 PM – 07.00 PM | BREAK | |
| 07.00 PM - 8.30 PM | Sponsored Dinner Symposium |
| 08.00 AM - 9.30 AM | Oral presentations from selected abstracts | |
| 09.30 AM – 09.45 AM | BREAK | |
| 9.45 AM – 10.15 AM | Academic / industry collaboration and perspectives | Kristian Reich, Hamburg, Germany |
| 10.15 AM – 10.45 AM | The Past, Present, and Future of Cell Therapies for Autoimmunity | Aimee Payne, Philadelphia, PA, USA |
| 10.45 AM – 11.15 AM | Lupus: New Developments | Joseph Merola, Boston MA, USA |
| 11.15 AM – 11.45 AM | The role of the target tissue in skin autoimmunity: pemphigus as a case study | Eli Sprecher, Tel Aviv, Israel |
| 11.45 PM – 12.00 PM | Oral presentations from selected abstracts | |
| 12.00 PM – 12.30 PM | BREAK | |
| 12.30 PM – 02.00 PM | Sponsored Lunch Symposium | |
| 02.00 PM – 02.30 PM | Artificial Intelligence in Dermatology | Philipp Tschandl, Vienna, Austria |
| 02.30 PM – 03.00 PM | Urticaria | Marcus Maurer, Berlin, Germany |
| 03.00 PM | Closing & Farewell |